Thalliumchlorid (201tl) Curium

Thallium (201Tl) Chloride is a radiopharmaceutical used for diagnostic imaging in nuclear medicine. This sterile, injectable solution helps assess cardiac function and detect abnormalities. Suitable for intravenous administration under medical supervision. Short-lived radioisotope for precise imaging studies.

Thallium (201Tl) Chloride is primarily used in nuclear medicine for myocardial perfusion imaging. It helps evaluate blood flow to the heart muscle, identifying areas of reduced perfusion that may indicate coronary artery disease. The radiotracer is also utilized in certain oncological and neurological imaging protocols to assess tissue viability and function.

After intravenous injection, Thallium (201Tl) Chloride distributes throughout the body, accumulating in tissues with high metabolic activity such as the heart. The radioactive decay of thallium emits gamma rays, which are detected by a gamma camera to create detailed images. Patients may experience mild discomfort at the injection site, but the solution is generally well-tolerated for diagnostic purposes.

Thallium (201Tl) Chloride should only be handled and administered by trained healthcare professionals in a controlled clinical setting. Pregnant or breastfeeding individuals should avoid exposure due to potential risks to the fetus or infant. Patients with known allergies to thallium or its compounds should inform their healthcare provider before administration.

No significant drug-drug interactions are reported with Thallium (201Tl) Chloride itself, but concurrent medications affecting cardiac function may influence imaging results. Alcohol and certain foods may interfere with test accuracy; follow fasting and medication guidelines provided by your healthcare provider. Always disclose all medications and supplements to your medical team prior to imaging.